Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ELETRIPTAN | 20MG | TABLET | Resolved | 2020-06-04 | 2020-07-23 | 116678 |
| TEVA-ELETRIPTAN | 40MG | TABLET | Resolved | 2018-03-13 | 2018-05-11 | 42553 |
| TEVA-EMTEC-30 | 30MG 300MG | TABLET | Resolved | 2025-08-21 | 2025-08-29 | 265785 |
| TEVA-EMTEC-30 | 30MG 300MG | TABLET | Resolved | 2024-02-08 | 2024-03-07 | 218946 |
| TEVA-EMTEC-30 | 30MG 300MG | TABLET | Resolved | 2025-09-25 | 2026-01-22 | 267859 |
| TEVA-EMTEC-30 | 30MG 300MG | TABLET | Resolved | 2022-12-01 | 2023-04-27 | 176773 |
| TEVA-EMTEC-30 | 30MG 300MG | TABLET | Resolved | 2025-07-18 | 2025-08-21 | 263107 |
| TEVA-EMTEC-30 | 30MG 300MG | TABLET | Resolved | 2022-07-25 | 2022-09-23 | 165450 |
| TEVA-EMTEC-30 | 30MG 300MG | TABLET | Resolved | 2021-07-08 | 2021-09-02 | 142183 |
| TEVA-EMTEC-30 | 300MG 30MG | TABLET | Resolved | 2021-02-18 | 2021-03-04 | 134346 |
| TEVA-EMTRICITABINE/TENOFOVIR | 200MG 300MG | TABLET | Resolved | 2020-11-06 | 2021-01-07 | 128004 |
| TEVA-EMTRICITABINE/TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2022-04-21 | 2023-06-21 | 159201 |
| TEVA-EMTRICITABINE/TENOFOVIR | 300MG 200MG | TABLET | Actual shortage | 2025-01-23 | 2025-05-22 | 248439 |
| TEVA-ENTACAPONE | 200MG | TABLET | Resolved | 2020-04-10 | 2020-04-23 | 111832 |
| TEVA-ENTACAPONE | 200MG | TABLET | Resolved | 2023-07-19 | 2023-08-04 | 199190 |
| TEVA-ENTACAPONE | 200MG | TABLET | Resolved | 2022-01-20 | 2022-02-25 | 153159 |
| TEVA-ENTACAPONE | 200MG | TABLET | Resolved | 2019-12-12 | 2020-03-05 | 101154 |
| TEVA-ENTACAPONE | 200MG | TABLET | Actual shortage | 2025-12-18 | 2026-01-15 | 274690 |
| TEVA-ENTACAPONE | 200MG | TABLET | Resolved | 2024-05-30 | 2024-08-30 | 229227 |
| TEVA-ERLOTINIB | 100MG | TABLET | Resolved | 2024-06-07 | 2024-08-08 | 229960 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RANITIDINE SOLUTION | 15MG | SOLUTION | Discontinued | 2019-04-11 | 2019-04-11 | 81304 |
| TEVA-RASAGILINE | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258753 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258473 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256079 |
| TEVA-RISEDRONATE | 150MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133905 |
| TEVA-RISPERIDONE | 2MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258679 |
| TEVA-RISPERIDONE | 3MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258685 |
| TEVA-RISPERIDONE | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258673 |
| TEVA-RISPERIDONE | 0.25MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258711 |
| TEVA-RISPERIDONE | 4MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258688 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258765 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258486 |
| TEVA-SUCRALFATE | 1G | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266359 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258478 |
| TEVA-TECNAL | 50MG 330MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258471 |
| TEVA-TECNAL C 1/2 | 50MG 330MG 30MG 40MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258462 |